Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Kozlowski

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Advanced Drug Delivery Reviews|July 11, 2006
Current and future issues in the manufacturing and development of monoclonal antibodiesSteven Kozlowski, Patrick Swann
Leukemia & Lymphoma|April 18, 2009
Biosimilars: considerations for an abbreviated pathwaySteven Kozlowski, Rachel Behrman
Annals of the New York Academy of Sciences|January 16, 2010
Hurdles and leaps for protein therapeuticsSteven Kozlowski, Barry Cherney, Raymond P Donnelly
Annual Review of Medicine|November 5, 2016
Biosimilars: The US Regulatory FrameworkLeah A Christl, Janet Woodcock, Steven Kozlowski
The New England Journal of Medicine|August 5, 2011
Developing the nation's biosimilars programSteven Kozlowski, Janet Woodcock, Karen Midthun, et al.
European Journal of Immunology|February 17, 2005
Peptide immunization excludes antigen-specific T cells from splenic lymphoid compartmentsLei Zhang, Elaine F Lizzio, Trina Chen, et al.
JAMA|April 20, 2026
Eliminating Unnecessary Animal TestingTracy Beth Høeg, Steven Kozlowski, Haleh Saber, et al.
Plos One|October 19, 2012
Oversulfated chondroitin sulfate inhibits the complement classical pathway by potentiating C1 inhibitorZhao-Hua Zhou, Mohsen Rajabi, Trina Chen, et al.
Plos One|April 20, 2012
Complement C1 esterase inhibitor levels linked to infections and contaminated heparin-associated adverse eventsZhao-Hua Zhou, Trina Chen, Kamalpreet Arora, et al.
Blood|March 16, 2002
CD43 polarization in unprimed T cells can be dissociated from raft coalescence by inhibition of HMG CoA reductaseElena Gubina, Trina Chen, Lei Zhang, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Advanced Drug Delivery Reviews|July 11, 2006
Current and future issues in the manufacturing and development of monoclonal antibodiesSteven Kozlowski, Patrick Swann
Leukemia & Lymphoma|April 18, 2009
Biosimilars: considerations for an abbreviated pathwaySteven Kozlowski, Rachel Behrman
Annals of the New York Academy of Sciences|January 16, 2010
Hurdles and leaps for protein therapeuticsSteven Kozlowski, Barry Cherney, Raymond P Donnelly
Annual Review of Medicine|November 5, 2016
Biosimilars: The US Regulatory FrameworkLeah A Christl, Janet Woodcock, Steven Kozlowski
The New England Journal of Medicine|August 5, 2011
Developing the nation's biosimilars programSteven Kozlowski, Janet Woodcock, Karen Midthun, et al.
European Journal of Immunology|February 17, 2005
Peptide immunization excludes antigen-specific T cells from splenic lymphoid compartmentsLei Zhang, Elaine F Lizzio, Trina Chen, et al.
JAMA|April 20, 2026
Eliminating Unnecessary Animal TestingTracy Beth Høeg, Steven Kozlowski, Haleh Saber, et al.
Plos One|October 19, 2012
Oversulfated chondroitin sulfate inhibits the complement classical pathway by potentiating C1 inhibitorZhao-Hua Zhou, Mohsen Rajabi, Trina Chen, et al.
Plos One|April 20, 2012
Complement C1 esterase inhibitor levels linked to infections and contaminated heparin-associated adverse eventsZhao-Hua Zhou, Trina Chen, Kamalpreet Arora, et al.
Blood|March 16, 2002
CD43 polarization in unprimed T cells can be dissociated from raft coalescence by inhibition of HMG CoA reductaseElena Gubina, Trina Chen, Lei Zhang, et al.
Pageof 4